» Articles » PMID: 27454675

Neurocognitive Enhancement or Impairment? A Systematic Meta-analysis of Prescription Stimulant Effects on Processing Speed, Decision-making, Planning, and Cognitive Perseveration

Overview
Specialty Pharmacology
Date 2016 Jul 26
PMID 27454675
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing numbers of adults, particularly college students, are misusing prescription stimulants primarily for cognitive/academic enhancement, so it is critical to explore whether empirical findings support neurocognitive benefits of prescription stimulants. Previous meta-analytic studies have supported small benefits from prescription stimulants for the cognitive domains of inhibitory control and memory; however, no meta-analytic studies have examined the effects on processing speed or the potential impairment on other domains of cognition, including planning, decision-making, and cognitive perseveration. Therefore, the present study conducted a meta-analysis of the available literature examining the effects of prescription stimulants on specific measures of processing speed, planning, decision-making, and cognitive perseveration among healthy adult populations. The meta-analysis results indicated a positive influence of prescription stimulant medication on processing speed accuracy, with an overall mean effect size of g = 0.282 (95% CI [0.077, 0.488]; n = 345). Neither improvements nor impairments were revealed for planning time, planning accuracy, advantageous decision-making, or cognitive perseveration; however, findings are limited by the small number of studies examining these outcomes. Findings support that prescription stimulant medication may indeed act as a neurocognitive enhancer for accuracy measures of processing speed without impeding other areas of cognition. Considering that adults are already engaging in illegal use of prescription stimulants for academic enhancement, as well as the potential for stimulant misuse to have serious side effects, the establishment of public policies informed by interdisciplinary research surrounding this issue, whether restrictive or liberal, is of critical importance. (PsycINFO Database Record

Citing Articles

Pharmacological Cognitive Enhancement Among International Medical Students: Assessing Study Habits as a Novel Factor.

Sheldon P, Mendez-Montejano J, Michalak A, Navarro J, Bradley C, Mongalo M Med Sci Educ. 2025; 34(6):1353-1360.

PMID: 39758485 PMC: 11699064. DOI: 10.1007/s40670-024-02113-w.


Categorical and dimensional aspects of stimulant medication effects in adult patients with ADHD and healthy controls.

Thunberg P, Reingardt M, Rode J, Msghina M Front Pharmacol. 2024; 15:1412178.

PMID: 39050752 PMC: 11266130. DOI: 10.3389/fphar.2024.1412178.


Changes in processing speed during early abstinence from alcohol dependence.

Powell A, Sumnall H, Kullu C, Owens L, Montgomery C J Psychopharmacol. 2024; 38(6):551-561.

PMID: 38804547 PMC: 11179317. DOI: 10.1177/02698811241254830.


Prescription Stimulant Misuse Among Nursing Students: A Systematic Review.

Magnotti S, Beatty A, Bickford E, Channell I, Weyandt L J Addict Nurs. 2023; 34(3):216-223.

PMID: 37669341 PMC: 10510837. DOI: 10.1097/JAN.0000000000000539.


On pharmacological neuroenhancement as part of the new neurorights' pioneering legislation in Chile: a perspective.

Cornejo-Plaza M, Saracini C Front Psychol. 2023; 14:1177720.

PMID: 37533709 PMC: 10393253. DOI: 10.3389/fpsyg.2023.1177720.


References
1.
Faraone S, Biederman J . Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis. J Atten Disord. 2002; 6(2):69-75. DOI: 10.1177/108705470200600203. View

2.
Faraone S, Biederman J, Spencer T, Aleardi M . Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed. 2007; 8(4):4. PMC: 1868385. View

3.
Ilieva I, Hook C, Farah M . Prescription Stimulants' Effects on Healthy Inhibitory Control, Working Memory, and Episodic Memory: A Meta-analysis. J Cogn Neurosci. 2015; 27(6):1069-89. DOI: 10.1162/jocn_a_00776. View

4.
Farah M . Emerging ethical issues in neuroscience. Nat Neurosci. 2002; 5(11):1123-9. DOI: 10.1038/nn1102-1123. View

5.
Kennedy R, Odenheimer R, Baltzley D, Dunlap W, Wood C . Differential effects of scopolamine and amphetamine on microcomputer-based performance tests. Aviat Space Environ Med. 1990; 61(7):615-21. View